vs

Side-by-side financial comparison of BranchOut Food Inc. (BOF) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

IMMUCELL CORP is the larger business by last-quarter revenue ($5.5M vs $4.0M, roughly 1.4× BranchOut Food Inc.). IMMUCELL CORP runs the higher net margin — -2.5% vs -50.6%, a 48.1% gap on every dollar of revenue. On growth, BranchOut Food Inc. posted the faster year-over-year revenue change (181.9% vs -8.4%). IMMUCELL CORP produced more free cash flow last quarter ($-1.8M vs $-2.1M). Over the past eight quarters, BranchOut Food Inc.'s revenue compounded faster (65.4% CAGR vs 3.9%).

Food Lion is an American regional supermarket chain headquartered in Salisbury, North Carolina, that operates over 1,000 supermarkets in 10 states: Delaware, Georgia, Kentucky, Maryland, North Carolina, South Carolina, Pennsylvania, Tennessee, Virginia, and West Virginia. The chain employs over 82,000 people. It was founded in 1957 as Food Town, a single grocery store in Salisbury. It later expanded to many locations across North Carolina. It was independently operated until it was acquired b...

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

BOF vs ICCC — Head-to-Head

Bigger by revenue
ICCC
ICCC
1.4× larger
ICCC
$5.5M
$4.0M
BOF
Growing faster (revenue YoY)
BOF
BOF
+190.3% gap
BOF
181.9%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
48.1% more per $
ICCC
-2.5%
-50.6%
BOF
More free cash flow
ICCC
ICCC
$332.2K more FCF
ICCC
$-1.8M
$-2.1M
BOF
Faster 2-yr revenue CAGR
BOF
BOF
Annualised
BOF
65.4%
3.9%
ICCC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BOF
BOF
ICCC
ICCC
Revenue
$4.0M
$5.5M
Net Profit
$-2.0M
$-139.7K
Gross Margin
7.6%
42.9%
Operating Margin
-47.6%
0.4%
Net Margin
-50.6%
-2.5%
Revenue YoY
181.9%
-8.4%
Net Profit YoY
-36.5%
80.1%
EPS (diluted)
$-0.15
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOF
BOF
ICCC
ICCC
Q4 25
$4.0M
Q3 25
$3.2M
$5.5M
Q2 25
$3.3M
$6.4M
Q1 25
$3.2M
$8.1M
Q4 24
$1.4M
$7.8M
Q3 24
$2.2M
$6.0M
Q2 24
$1.4M
$5.5M
Q1 24
$1.5M
$7.3M
Net Profit
BOF
BOF
ICCC
ICCC
Q4 25
$-2.0M
Q3 25
$-1.6M
$-139.7K
Q2 25
$-1.6M
$501.9K
Q1 25
$-918.4K
$1.4M
Q4 24
$-1.5M
Q3 24
$-1.3M
$-701.7K
Q2 24
$-942.6K
$-1.5M
Q1 24
$-1.1M
$-437.9K
Gross Margin
BOF
BOF
ICCC
ICCC
Q4 25
7.6%
Q3 25
17.7%
42.9%
Q2 25
18.4%
43.7%
Q1 25
17.3%
41.6%
Q4 24
0.9%
36.5%
Q3 24
15.4%
26.3%
Q2 24
10.9%
22.5%
Q1 24
19.3%
31.6%
Operating Margin
BOF
BOF
ICCC
ICCC
Q4 25
-47.6%
Q3 25
-44.3%
0.4%
Q2 25
-40.8%
8.8%
Q1 25
-21.4%
13.9%
Q4 24
-80.7%
8.0%
Q3 24
-41.4%
-9.6%
Q2 24
-60.6%
-25.3%
Q1 24
-69.9%
-4.1%
Net Margin
BOF
BOF
ICCC
ICCC
Q4 25
-50.6%
Q3 25
-48.8%
-2.5%
Q2 25
-48.6%
7.8%
Q1 25
-28.8%
17.9%
Q4 24
-104.5%
Q3 24
-58.3%
-11.7%
Q2 24
-69.2%
-28.0%
Q1 24
-71.6%
-6.0%
EPS (diluted)
BOF
BOF
ICCC
ICCC
Q4 25
$-0.15
Q3 25
$-0.14
$-0.02
Q2 25
$-0.17
$0.06
Q1 25
$-0.11
$0.16
Q4 24
$-0.16
$0.09
Q3 24
$-0.19
$-0.09
Q2 24
$-0.22
$-0.20
Q1 24
$-0.26
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOF
BOF
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$3.9M
Total DebtLower is stronger
$4.9M
$9.5M
Stockholders' EquityBook value
$5.6M
$29.8M
Total Assets
$14.5M
$45.7M
Debt / EquityLower = less leverage
0.89×
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOF
BOF
ICCC
ICCC
Q4 25
Q3 25
$3.9M
Q2 25
Q1 25
Q4 24
$3.8M
Q3 24
Q2 24
$1.3M
Q1 24
$960.3K
Total Debt
BOF
BOF
ICCC
ICCC
Q4 25
$4.9M
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
BOF
BOF
ICCC
ICCC
Q4 25
$5.6M
Q3 25
$5.1M
$29.8M
Q2 25
$3.5M
$29.9M
Q1 25
$3.9M
$29.0M
Q4 24
$2.3M
$27.5M
Q3 24
$1.5M
$26.4M
Q2 24
$2.0M
$23.5M
Q1 24
$1.7M
$24.6M
Total Assets
BOF
BOF
ICCC
ICCC
Q4 25
$14.5M
Q3 25
$14.7M
$45.7M
Q2 25
$13.2M
$46.7M
Q1 25
$14.1M
$45.6M
Q4 24
$12.9M
$45.1M
Q3 24
$9.6M
$44.4M
Q2 24
$6.7M
$41.9M
Q1 24
$2.7M
$43.1M
Debt / Equity
BOF
BOF
ICCC
ICCC
Q4 25
0.89×
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOF
BOF
ICCC
ICCC
Operating Cash FlowLast quarter
$-1.9M
$-1.2M
Free Cash FlowOCF − Capex
$-2.1M
$-1.8M
FCF MarginFCF / Revenue
-52.6%
-32.3%
Capex IntensityCapex / Revenue
4.3%
10.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.7M
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOF
BOF
ICCC
ICCC
Q4 25
$-1.9M
Q3 25
$-1.1M
$-1.2M
Q2 25
$-2.0M
$1.6M
Q1 25
$-1.9M
$1.6M
Q4 24
$-1.6M
$-3.1K
Q3 24
$-1.9M
$-639.3K
Q2 24
$-853.9K
$581.8K
Q1 24
$-503.6K
$418.5K
Free Cash Flow
BOF
BOF
ICCC
ICCC
Q4 25
$-2.1M
Q3 25
$-1.2M
$-1.8M
Q2 25
$-2.1M
$1.4M
Q1 25
$-2.3M
$1.2M
Q4 24
$-2.3M
$-199.3K
Q3 24
$-3.4M
$-727.7K
Q2 24
$-1.4M
$471.0K
Q1 24
$-553.6K
$348.1K
FCF Margin
BOF
BOF
ICCC
ICCC
Q4 25
-52.6%
Q3 25
-37.4%
-32.3%
Q2 25
-64.5%
22.4%
Q1 25
-72.2%
15.4%
Q4 24
-163.6%
-2.6%
Q3 24
-157.9%
-12.1%
Q2 24
-101.3%
8.6%
Q1 24
-37.7%
4.8%
Capex Intensity
BOF
BOF
ICCC
ICCC
Q4 25
4.3%
Q3 25
2.6%
10.8%
Q2 25
3.4%
2.4%
Q1 25
11.8%
4.1%
Q4 24
51.1%
2.5%
Q3 24
70.8%
1.5%
Q2 24
38.6%
2.0%
Q1 24
3.4%
1.0%
Cash Conversion
BOF
BOF
ICCC
ICCC
Q4 25
Q3 25
Q2 25
3.19×
Q1 25
1.09×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons